Navigation Links
Mustafa al'Absi Ph.D. and national team awarded major NIH grant
Date:9/26/2007

Mustafa alAbsi, Ph.D., and a team of national collaborators have received a four-year grant of $1.6 million from the National Institutes of Health (NIH) for their research, AutoSense: Quantifying Exposures to Addictive Substances and Psychosocial Stress. alAbsi is a professor and founding director of Duluth Medical Research Institute at the University of Minnesota Medical SchoolDuluth Campus.

The project is among the first of 45 funded by the National Institutes of Health (NIH) as part of the Genes, Environment and Health Initiative (GEI). alAbsis study falls under the Exposure Biology Program coordinated primarily by the National Institute of Environmental Health Sciences (NIEHS) in partnership with the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute on Drug Abuse (NIDA), all of which are part of NIH. The Exposure Biology Program supports interdisciplinary teams of basic scientists, bioengineers, physician-scientists and others working toward a variety of goals, including developing environmental sensors for measuring toxins, dietary intake, physical activity, psychosocial stress and addictive substances.

What we are doing with this research is unique and innovative, particularly because we are moving the research out of the laboratory and into the real world, alAbsi commented. Success with this research could lead to important improvements in how people at high risk for medical or psychosocial problems are monitored and treated.

The goal of alAbsis research is to quantify the relationship between stress and stress-related illnesses, including addiction. alAbsi will work in collaboration with investigators at the University of Memphis, Ohio State University and SpectRx, a Georgia biotech company. The clinical and human testing will occur at the Medical SchoolDuluth Campus. alAbsi will be assisted by Ruth Westra, D.O., and Sharon Allen, M.D., Ph.D., who will coordinate the medical monitoring in Duluth and Minneapolis, and Lorentz E. Wittmers Jr. M.D., Ph.D., who will assist in physiological testing.

Test participants would be connected to portable wireless sensors and data would be transmitted to a data repository. First steps in the research will involve assembling the biochemistry and software technology and testing them in a controlled laboratory setting with healthy people as subjects. Once scientists are certain the technology performs as expected, they hope to launch future studies to measure how the heart, blood vessels and blood chemistry are reacting 24 hours a day to real-world living situations.

Commenting about the body of proposals funded by the NIH as part of the Genes, Environment and Health Initiative, Department of Health and Human Services Secretary Mike Leavitt said, "This is groundbreaking research in understanding the complex factors that contribute to health and disease. Researchers have long known that our genes, our environmental exposures and our own behavioral choices all have an influence on our health. This new initiative will use innovative genomic tools as well as new instruments for measuring environmental factors from diet and physical activity to stress and substance addiction in order to begin sorting out how these different factors affect a person's risk for a number of health conditions."


'/>"/>

Contact: Michelle Juntunen
m.juntunen@mmf.umn.edu
218-726-6876
University of Minnesota
Source:Eurekalert

Related biology news :

1. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
2. International trial of two microbicides begins
3. International HapMap consortium expands mapping effort
4. BioMed Central welcomes the new National Institutes of Health public access policy
5. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
6. Canadian youth 4th highest in international obesity study
7. International Team Determines Geographic Origin of Leprosy
8. Team of international scientists departs today to discover the unknown in Chinas Himalayan region
9. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
10. Tropical dry forests receive international recognition
11. Open Source Biotechnology alliance for international agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK Business ... US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants module ... and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology: